Advertisement
Singapore markets close in 6 hours 18 minutes
  • Straits Times Index

    3,293.62
    +20.90 (+0.64%)
     
  • Nikkei

    38,337.60
    +785.44 (+2.09%)
     
  • Hang Seng

    17,069.10
    +240.17 (+1.43%)
     
  • FTSE 100

    8,044.81
    +20.94 (+0.26%)
     
  • Bitcoin USD

    66,643.43
    -215.51 (-0.32%)
     
  • CMC Crypto 200

    1,433.64
    +18.88 (+1.33%)
     
  • S&P 500

    5,070.55
    +59.95 (+1.20%)
     
  • Dow

    38,503.69
    +263.71 (+0.69%)
     
  • Nasdaq

    15,696.64
    +245.33 (+1.59%)
     
  • Gold

    2,331.50
    -10.60 (-0.45%)
     
  • Crude Oil

    83.30
    -0.06 (-0.07%)
     
  • 10-Yr Bond

    4.5980
    -0.0250 (-0.54%)
     
  • FTSE Bursa Malaysia

    1,566.46
    +4.82 (+0.31%)
     
  • Jakarta Composite Index

    7,169.61
    +58.79 (+0.83%)
     
  • PSE Index

    6,571.61
    +64.81 (+1.00%)
     

Is It Time to Buy the S&P 500's 4 Worst-Performing Stocks of 2023?

Is It Time to Buy the S&P 500's 4 Worst-Performing Stocks of 2023?

After declining 19% in 2022, the S&P 500 has risen about 4% this year as investors grew accustomed to inflation, rising interest rates, and other macro headwinds. Let's see if the four worst-performing S&P 500 components so far in 2023 -- Lumen Technologies (NYSE: LUMN), Moderna (NASDAQ: MRNA), Baxter International (NYSE: BAX) and Pfizer (NYSE: PFE) -- are actually contrarian buys.